EDMONTON, Nov. 26 /CNW/ - Isotechnika Inc. announced today that the Company has been issued Norwegian Patent No. 324042 for its lead immunosuppressive drug, ISA247. Obtaining the patent in Norway completes the protection over the novel structural features of ISA247 in Europe.
